<DOC>
	<DOCNO>NCT00627848</DOCNO>
	<brief_summary>The purpose study investigate effect rivastigmine give acute dose compare placebo 1 month chronic dose fMRI response face recognition task . Furthermore , aim investigate whether fMRI response correlate long term treatment effect 6 month 12 month .</brief_summary>
	<brief_title>Rivastigmine Mild Alzheimer 's Disease , FMRI Study</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Rivastigmine</mesh_term>
	<criteria>Probable Alzheimer 's disease accord NINCDSADRDA criterion mild disease , CDR 1 clinician plan start anticholinesterase treatment cognitive impairment reason Alzheimer 's disease severe depression unstable physical disease medal body prevention MRI examination , claustrophobia cardiac pacemaker significant neurologic psychiatric disease contraindication anticholinesterase treatment</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>fmri</keyword>
	<keyword>face recognition</keyword>
	<keyword>rivastigmine</keyword>
</DOC>